Concourse Financial Group Securities, Inc. Alpha Tau Medical Ltd. Transaction History
Concourse Financial Group Securities, Inc.
- $1.56 Billion
- Q2 2024
Number of Shares
0
Previous 0
NaN%
Holding current value
$0
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding DRTS
# of Institutions
28Shares Held
1.42MCall Options Held
0Put Options Held
0-
Levin Capital Strategies, L.P. New York, NY280KShares$673,1010.07% of portfolio
-
Hoyle Cohen, LLC269KShares$645,8110.05% of portfolio
-
High Tower Advisors, LLC Chicago, IL231KShares$553,6890.0% of portfolio
-
Corbin Capital Partners, L.P. New York, NY97.2KShares$233,2720.69% of portfolio
-
ETF Managers Group, LLC Summit, NJ66.3KShares$159,1820.01% of portfolio
About Alpha Tau Medical Ltd.
- Ticker DRTS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 69,011,296
- Market Cap $166M
- Description
- Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, and breast canc...